The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
Professor George Daley from the Children’s Hospital Boston, Harvard Medical School, Boston, MA will be visiting Lund on December 16-18, 2015 in connection with Roger Rönn's thesis defense.
He will give a lecture entitled "Stem Cell Science and its Social Context" on Thursday December 17 at 10 am in the LUX Aula, Helgonavägen 3, 223 62 Lund.
Roger Rönn will defend his thesis entitled "Towards Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells - Strategies to Overcome the Hurdles" on December 17 at 2 pm in the Belfrage Lecture Hall, BMC D15.
Faculty opponent: Professor George Q. Daley, Children’s Hospital Boston, Harvard Medical School, Boston, MA, U.S.A
Main supervisor: Assistant Professor Niels-Bjarne Woods
"Post-transcriptional gene expression dynamics in stem and cancer cells"
Speaker: Cristian Bellodi
When: November 25 at 14:45
Venue: Segerfalk Lecture Hall
On October 23, Maria Dahl successfully defended her thesis entitled "Cell and gene therapy for blood disorders. Modeling of novel treatment strategies for Gaucher type 1 disease and Diamond-Blackfan anemia in mice". The Faculty opponent was Professor Juan Bueren from the Division of Hematopoietic Innovative Therapies, CIEMAT/ CIBERER, Madrid, Spain.
Congratulations Dr Dahl!
Maria Dahl will defend her thesis entitled "Cell and gene therapy for blood disorders. Modeling of novel treatment strategies for Gaucher type 1 disease and Diamond-Blackfan anemia in mice" on October 23 at 13:00 in the Segerfalk Lecture Hall.
Faculty opponent: Professor Juan Bueren, Division of Hematopoietic Innovative Therapies, CIEMAT/ CIBERER, Madrid, Spain
Main supervisor: Professor Stefan Karlsson